QLGN QUALIGEN THERAPEUTICS INC Management Changes 8-K Filing 2024 - Management Changes Qualigen Therapeutics appointed Graydon Bensler as an independent board member and chairman of the audit committee, with a Director Agreement filed as an exhibit.Get access to all SEC 8-K filings of the QUALIGEN THERAPEUTICS INC